BeiGene to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
04 Junio 2024 - 5:01AM
Business Wire
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global
oncology company, today announced the Company will participate in
the Goldman Sachs 45th Annual Global Healthcare Conference on
Tuesday, June 11, 2024 with a fireside chat at 1:20 pm EDT.
Live webcast of this event can be accessed from the investors
section of BeiGene’s website at http://ir.beigene.com,
https://hkexir.beigene.com/, https://sseir.beigene.com/. Archived
replay will be available for 180 days following the event.
About BeiGene
BeiGene is a global oncology company that is discovering and
developing innovative treatments that are more accessible and
affordable to cancer patients worldwide. With a broad portfolio, we
are expediting development of our diverse pipeline of novel
therapeutics through our internal capabilities and collaborations.
We are committed to radically improving access to medicines for far
more patients who need them. Our growing global team of more than
10,000 colleagues spans five continents. To learn more about
BeiGene, please visit www.beigene.com and follow us on LinkedIn, X
(formerly known as Twitter) and Facebook.
Forward-Looking Statements
This presentation may contain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
and other federal securities laws, including statements regarding
BeiGene's plans, commitments, aspirations and goals related to
BeiGene’s medicines and drug candidates. Actual results may differ
materially from those indicated in the forward-looking statements
as a result of various important factors which are discussed in the
section entitled “Risk Factors” in BeiGene’s most recent quarterly
report on Form 10-Q filed with the U.S. Securities and Exchange
Commission (“SEC”) as well as discussions of potential risks,
uncertainties, and other important factors in BeiGene's subsequent
filings with the SEC. All information in this presentation is as of
the date presented, and BeiGene undertakes no duty to update such
information unless required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240604005765/en/
Investors: Liza Heapes +1 857-302-5663 ir@beigene.com
Media: Kyle Blankenship +1 667-351-5176
media@beigene.com
BeiGene (NASDAQ:BGNE)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
BeiGene (NASDAQ:BGNE)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024